Back to search

Article

Potent and selective repression of <i>SCN9A</i> by engineered zinc finger repressors for the treatment of neuropathic pain

2024-09-11

Abstract excerpt

<h4>ABSTRACT</h4> Peripheral neuropathies are estimated to affect several million patients in the US with no long-lasting therapy currently available. In humans, the Nav1.7 sodium channel, encoded by the SCN9A gene, is involved in a spectrum of inherited neuropathies, and has emerged as a promising target for analgesic drug development. The development of a selective Nav1.7 inhibitor has been challenging, in par...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
735d280e-8d45-54ba-8c5c-fa625f6e2f8e
DOI
10.1101/2024.09.06.609976
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Potent and selective repression of <i>SCN9A</i> by engineered zinc finger repressors for the treatment of neuropathic painDOI 10.1101/2024.09.06.609976
Select a neighboring publication to make it the new centre.